Drugs / Ginkgo biloba dispersible tablets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03090516 | Aug 2016 → Mar 2020 | Alzheimer disease | The First Affiliated Hospital with Nanjing Medical University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ginkgo biloba dispersible tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03090516 ↗ |